Xtampza Capsule, Extended Release
Product Images NDC 24510-110

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xtampza (NDC 24510-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Collegium Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Xtampza 01)

FDA Label Image

Chemical Structure (Xtampza 02)

FDA Label Image

Figure 2 (Xtampza 03)

The text describes a comparison between a group of subjects taking XTAMPZAER and a group taking placebo. The proportions of the subjects are listed as 504, 30, 204, and 104, however, it is not clear what these numbers are referring to. The chart also displays percentage ranges for reduction in pain, but without context, it is not possible to determine the efficacy of either treatment.*

FDA Label Image

Figure 1 (Xtampza 04)

FDA Label Image

Figure 2 (Xtampza 05)

FDA Label Image

Figure 3 (Xtampza 06)

FDA Label Image

Figure 4 (Xtampza 07)

FDA Label Image

Principal Display Panel (9 mg Capsule Bottle Label)

This appears to be a medication label with information such as the name of the drug "Onjeodone" and the dosage of 9 mg per capsule. The manufacturer's name is listed as Pathoon Pharmaceuticals Inc. with an address in Cincinnati, Ohio. The cost is listed as 85 cents per capsule.*

FDA Label Image

Principal Display Panel (13.5 mg Capsule Bottle Label)

This is a medication label for Oxycodone capsules. Each capsule contains 13.5mg Oxycodone hydrochloride and must be taken with food to avoid decreased absorption. A medication guide should be given to the patient upon dispensing. The manufacturer is Partheon Pharmaceuticals in Cincinnati, OH.*

FDA Label Image

Principal Display Panel (18 mg Capsule Bottle Label)

This text is a prescription drug label for Xtampza, a medication containing Oxycodone. It is available in capsules, and each capsule contains 18mg of Oxycodone, which is equivalent to 20mg of Oxycodone Hydrochloride. Users are advised to take with food, as taking it on an empty stomach can decrease drug absorption. Dispensers are directed to provide accompanying medication guides to the patient upon dispensing. The manufacturer of this medication is Patheon Pharmaceuticals Inc. located in Cincinnati, OH.*

FDA Label Image

Principal Display Panel (27 mg Capsule Bottle Label)

This is a medication containing 100 capsules of Oxycodone with each capsule containing 27 mg of the drug which is equivalent to 30 mg Oxycodone Hydrochloride. The usual dosage should be read before taking the medication, and it should be taken with food to prevent adverse effects due to drug absorption. The medication guide provided with the package should be given to the patient by the dispenser. The manufacturer of this medication is Patheon Pharmaceuticals Inc. located in Cincinnati, OH.*

FDA Label Image

Principal Display Panel (36 mg Capsule Bottle Label)

This is a medication for Oxycodone with a usual dosage. The bottle contains 100 capsules of 36mg Oxycodone each, which is equivalent to 40mg of Oxycodone Hydrochloride. The prescription must be given with accompanying literature and medication guide to the patient upon dispensing. The bottle lists the NDC number as 24510-140-10 and indicates the medication is manufactured by Patheon Pharmaceuticals Inc. in Cincinnati, OH.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.